NHI to Attend the 23rd Annual Wells Fargo Real Estate Securities Conference

MURFREESBORO, TN / ACCESSWIRE / February 21, 2020 / National Health Investors (NYSE:NHI) announced that Eric Mendelsohn, President and CEO, Kevin Pascoe, Chief Investment Officer, and John Spaid, Chief Financial Officer, will be meeting with institutional investors at the Wells Fargo Real Estate Securities Conference on Wednesday, February 26, 2020 at the InterContinental New York Barclay in New York, NY.

About NHI

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. For more information, visit www.nhireit.com.

Contact:
Dana Hambly
Director, Investor Relations
Phone: (615) 890-9100

SOURCE: National Health Investors

View source version on accesswire.com:
https://www.accesswire.com/577253/NHI-to-Attend-the-23rd-Annual-Wells-Fargo-Real-Estate-Securities-Conference

Staff

Recent Posts

Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024

NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…

33 minutes ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…

33 minutes ago

Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting

Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…

33 minutes ago

Sunshine Biopharma Launches a New Generic Prescription Drug

FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…

33 minutes ago